Sox13 is a novel flow-sensitive transcription factor that prevents inflammation by repressing chemokine expression in endothelial cells

Overview of attention for article published in Frontiers in Cardiovascular Medicine, September 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter: 3 X users

Readers on

mendeley: 3 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 3,072 followers.

RRIDs were included in the Frontiers in Cardiovascular Medicine paper "Sox13 is a novel flow-sensitive transcription fact…" (https://t.co/mZ6xcwT0pV). Thank you for making your #methodsmatter. #ReproducibleResearch

27 Oct 2022

Reply Repost Favourite

Excited to share our work on Sox13-mediated repression of pro-inflammatory chemokines in ECs under stable flow, now out in @FrontCVMedicine

20 Oct 2022

Reply Repost Favourite

New Research: Sox13 is a novel flow-sensitive transcription factor that prevents inflammation by repressing chemokine expression in endothelial cells: Atherosclerosis is a chronic inflammatory disease and occurs preferentially in arterial… https://t.co/DaX

06 Oct 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.